Biotechnology consortium to create a platform for the development and production of RNA-based drugs for rare diseases.
Specialties
oligonucleotide, RNA, siRNA, aptamer, miRNA, biosynthesis, RNA production, Artificial Inteligence, therapy development, nanotechnology, Drug delivery, Bioconjugates, scale-up, Rare diseases, R&D, drug discovery, end-to-end platform, and oligonucleotide-based therapies
Company Details
- Founded
- -
- Address
- Spain, Es
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://oligofastx.com/
- Keywords
- oligonucleotide, RNA, siRNA, aptamer, miRNA, biosynthesis, RNA production, Artificial Inteligence, therapy development, nanotechnology, Drug delivery, Bioconjugates, scale-up, Rare diseases, R&D, drug discovery, end-to-end platform, oligonucleotide-based therapies.
- HQ
- Spain
Oligofastx Questions
Oligofastx's website is https://oligofastx.com/
Oligofastx's LinkedIn profile is https://es.linkedin.com/company/oligofastx
Oligofastx's industry is
Biotechnology Research
Oligofastx's top competitors are
Fertinagro Biotech,
Nostrum Biodiscovery,
Actual Talent Spain,
Bdi Biotech,
53biologics,
Biotech Healthcare,
Oryzon Genomics Sa,
Nanovex Biotechnologies,
Sylentis,
Vytrus Biotech.
Oligofastx's categories are Biotechnology Research
Oligofastx's founding year is 2021
